Androgens in human breast carcinoma

Medical Molecular Morphology

Volumn 43, Issue 2, 2010, Pages 75-81

  Suzuki, Takashi ^a   Miki, Yasuhiro ^b   Takagi, Kiyoshi ^a   Hirakawa, Hisashi ^b   Moriya, Takuya ^c   Ohuchi, Noriaki ^a   Sasano, Hironobu ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU ROSAI HOSPITAL   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

5 Reductase; Androgen; Androgen receptor; Aromatase; Breast cancer; Estrogen receptor

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE 5; 17BETA HYDROXYSTEROID DEHYDROGENASE 5ALPHA REDUCTASE; ANASTROZOLE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTANOLONE BEZONATE; ANDROSTANOLONE DERIVATIVE; ANDROSTENEDIONE; ANTIANDROGEN; ANTIESTROGEN; AROMATASE; AROMATASE INHIBITOR; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; EXEMESTANE; LETROZOLE; MIBOLERONE; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ANDROGEN METABOLISM; ANDROGEN SYNTHESIS; ANDROSTENEDIONE BLOOD LEVEL; ANTINEOPLASTIC ACTIVITY; APOCRINE CARCINOMA; APOCRINE GLAND; BLOOD; BREAST; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CARCINOMA CELL; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ESTROGEN THERAPY; GENE EXPRESSION; HISTOPATHOLOGY; HORMONE SYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; MICROARRAY ANALYSIS; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION;

ANDROGENS; AROMATASE; BREAST NEOPLASMS; DIHYDROTESTOSTERONE; FEMALE; HUMANS; RECEPTORS, ESTROGEN;

EID: 77956045310     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-010-0494-3     Document Type: Conference Paper

References (63)

1. J.A. Soreide O.A. Lea J.E. Varhaug A. Skarstein S. Kvinnsland 1992 Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment Eur J Surg Oncol 18 112 118 1582503
2. J.J. Isola 1993 Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors J Pathol 170 31 35 10.1002/path.1711700106 8100853
3. V. Kuenen-Boumeester T.H. Van der Kwast C.C. Claassen M.P. Look G.S. Liem J.G. Klijn S.C. Henzen-Logmans 1996 The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters Eur J Cancer 32A 1560 1565 10.1016/0959-8049(96)00112-8 8911118
4. M. Brys M. Wojcik H. Romanowicz-Makowska W.M. Krajewska 2002 Androgen receptor status in female breast cancer: RT-PCR and Western blot studies J Cancer Res Clin Oncol 128 85 90 10.1007/s004320100294 11862478
5. F. Moinfar M. Okcu O. Tsybrovskyy P. Regitnig S.F. Lax W. Weybora M. Ratschek F.A. Tavassoli H. Denk 2003 Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies Cancer (Phila) 98 703 711 10.1002/cncr.11532
6. Y. Ogawa E. Hai K. Matsumoto K. Ikeda S. Tokunaga H. Nagahara K. Sakurai T. Inoue Y. Nishiguchi 2008 Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers Int J Clin Oncol 13 431 435 10.1007/s10147-008-0770-6 18946753
7. K.L. Burnstein 2005 Regulation of androgen receptor levels: implications for prostate cancer progression and therapy J Cell Biochem 95 657 669 10.1002/jcb.20460 15861399
8. F. Labrie V. Luu-The C. Labrie A. Belanger J. Simard S.X. Lin G. Pelletier 2003 Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone Endocr Rev 24 152 182 10.1210/er.2001-0031 12700178
9. C. Recchione E. Venturelli A. Manzari A. Cavalleri A. Martinetti G. Secreto 1995 Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues J Steroid Biochem Mol Biol 52 541 546 10.1016/0960-0760(95)00017-T 7779758
10. R. Shibuya T. Suzuki Y. Miki K. Yoshida T. Moriya K. Ono J.I. Akahira T. Ishida H. Hirakawa D.B. Evans H. Sasano 2008 Intratumoral concentration of sex steroids and expression of sex steroidproducing enzymes in ductal carcinoma in situ of human breast Endocr Relat Cancer 15 113 124 10.1677/ERC-07-0092 18310280
11. R. Mindnich G. Moller J. Adamski 2004 The role of 17betahydroxysteroid dehydrogenases Mol Cell Endocrinol 218 7 20 10.1016/j.mce.2003.12.006 15130507
12. S. Nagasaki Y. Miki J. Akahira T. Suzuki H. Sasano 2009 17betahydroxysteroid dehydrogenases in human breast cancer Ann N Y Acad Sci 55 25 32 10.1111/j.1749-6632.2008.03682.x
13. I. Dufort P. Rheault X.F. Huang P. Soucy V. Luu-The 1999 Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase Endocrinology 140 568 574 10.1210/en.140.2.568 9927279
14. T.M. Penning M.E. Burczynski J.M. Jez H.K. Lin H. Ma M. Moore K. Ratnam N. Palackal 2001 Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) Mol Cell Endocrinol 171 137 149 10.1016/S0303-7207(00)00426-3 11165022
15. Q. Ji C. Aoyama Y.D. Nien P.I. Liu P.K. Chen L. Chang F.Z. Stanczyk A. Stolz 2004 Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling Cancer Res 64 7610 7617 10.1158/0008-5472.CAN-04-1608 15492289
16. O.O. Oduwole Y. Li V.V. Isomaa A. Mäntyniemi A.E. Pulkka Y. Soini P.T. Vihko 2004 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer Cancer Res 15 7604 609 10.1158/0008-5472.CAN- 04-0446
17. P. Vihko A. Herrala P. Harkonen V. Isomaa H. Kaija R. Kurkela Y. Li L. Patrikainen A. Pulkka P. Soronen S. Torn 2005 Enzymes as modulators in malignant transformation J Steroid Biochem Mol Biol 93 277 283 10.1016/j.jsbmb.2005.01. 002 15860271
18. T. Suzuki A.D. Darnel J.I. Akahira N. Ariga S. Ogawa C. Kaneko J. Takeyama T. Moriya H. Sasano 2001 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions J Clin Endocrinol Metab 86 2250 2257 10.1210/jc.86.5.2250 11344235
19. B. Han S. Li D. Song D. Poisson-Paré G. Liu V. Luu-The J. Ouellet S. Li F. Labrie G. Pelletier 2008 Expression of 17betahydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters J Steroid Biochem Mol Biol 112 194 200 10.1016/j.jsbmb.2008.10.004 18996480
20. T. Suzuki Y. Miki Y. Nakamura T. Moriya K. Ito N. Ohuchi H. Sasano 2005 Sex-steroid producing enzymes in human breast cancer Endocr Relat Cancer 12 701 720 10.1677/erc.1.00834 16322318
21. V. Luu-The I. Dufort G. Pelletier F. Labrie 2001 Type 5 17betahydroxysteroid dehydrogenase: its role in the formation of androgens in women Mol Cell Endocrinol 171 77 82 10.1016/S0303-7207(00)00425-1 11165014
22. J.P. Wiebe D. Muzia J. Hu D. Szwajcer S.A. Hill J.L. Seachrist 2000 The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion Cancer Res 60 936 943 10706108
23. T. Suzuki B.A. Murry A.D. Darnel H. Sasano 2002 Progesterone metabolism in human leukemic monoblast U937 cells Endocr J 49 539 546 10.1507/endocrj.49. 539 12507272
24. J.P. Wiebe L. Souter G. Zhang 2006 Dutasteride affects progesterone metabolizing enzyme activity/expression in human breast cell lines resulting in suppression of cell proliferation and detachment J Steroid Biochem Mol Biol 100 129 140 10.1016/j.jsbmb.2006.03.010 16806904
25. P. Mistry K. Griffiths P.V. Maynard 1986 Endogenous C19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors J Steroid Biochem 24 1117 1125 10.1016/0022-4731(86)90372-9 3736038
26. P.G. Spinola B. Marchetti Y. Merand A. Belanger F. Labrie 1988 Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors Breast Cancer Res Treat 12 287 296 10.1007/BF01811241 3147727
27. K. Sonne-Hansen A.E. Lykkesfeldt 2005 Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line J Steroid Biochem Mol Biol 93 25 34 10.1016/j.jsbmb.2004.11.005 15748829
28. T. Suzuki Y. Miki T. Moriya J. Akahira T. Ishida H. Hirakawa Y. Yamaguchi S. Hayashi H. Sasano 2007 5alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production Int J Cancer 20 285 291 10.1002/ijc.22317
29. M. Baum 2004 Current status of aromatase inhibitors in the management of breast cancer and critique of the NCIC MA-17 trial Cancer Control 11 217 221 15284712
30. Y. Miki T. Suzuki C. Tazawa Y. Yamaguchi K. Kitada S. Honma T. Moriya H. Hirakawa D.B. Evans S. Hayashi N. Ohuchi H. Sasano 2007 Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells Cancer Res 67 3945 3954 10.1158/0008-5472.CAN-06- 3105 17440110
31. T. Suzuki Y. Miki T. Moriya J. Akahira H. Hirakawa N. Ohuchi H. Sasano 2007 In situ production of sex steroids in human breast carcinoma Med Mol Morphol 40 121 127 10.1007/s00795-007-0365-8 17874044
32. R. Poulin D. Baker F. Labrie 1988 Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line Breast Cancer Res Treat 12 213 225 10.1007/BF01805942 3242650
33. Y. de Launoit S. Dauvois M. Dufour J. Simard F. Labrie 1991 Inhibition of cell cycle kinetics and proliferation by the androgen 5α- dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16′α- chloro-3′,17β-dihydroxy-estra-1′,3′,5′-(10′) triene-7′α-yl] undecanamide in human breast cancer ZR-75-1 cells Cancer Res 51 2797 2802 2032219
34. S. Ando F. De Amicis V. Rago A. Carpino M. Maggiolini M.L. Panno M. Lanzino 2002 Breast cancer: from estrogen to androgen receptor Mol Cell Endocrinol 193 121 128 10.1016/S0303-7207(02)00105-3 12161011
35. J. Lapointe C. Labrie 2001 Role of the cyclin-dependent kinase inhibitor p27(Kip1) in androgen-induced inhibition of CAMA-1 breast cancer cell proliferation Endocrinology 142 4331 4338 10.1210/en.142.10.4331 11564693
36. S. Dauvois C.S. Geng C. Levesque Y. Merand F. Labrie 1991 Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice Cancer Res 51 3131 3135 2039992
37. L.F. Macedo Z. Guo S.L. Tilghman G.J. Sabnis Y. Qiu A. Brodie 2006 Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole Cancer Res 66 7775 7782 10.1158/0008-5472.CAN-05-3984 16885381
38. S.N. Birrell J.M. Bentel T.E. Hickey C. Ricciardelli M.A. Weger D.J. Horsfall W.D. Tilley 1995 Androgens induce divergent proliferative responses in human breast cancer cell lines J Steroid Biochem Mol Biol 52 459 467 10.1016/0960-0760(95)00005-K 7748811
39. J. Zhang Y. Sun Y. Liu Y. Sun D.J. Liao 2004 Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland Oncol Rep 12 709 716 15375489
40. R.E. Hall J.O. Aspinall D.J. Horsfall S.N. Birrell J.M. Bentel R.L. Sutherland W.D. Tilley 1996 Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer Br J Cancer 74 1175 1180 8883401
41. R.M. Bryan R.J. Mercer R.C. Bennett G.C. Rennie T.H. Lie F.J. Morgan 1984 Androgen receptors in breast cancer Cancer (Phila) 54 2436 2440 10.1002/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H
42. A.A. Peters G. Buchanan C. Ricciardelli T. Bianco-Miotto M.M. Centenera J.M. Harris S. Jindal D. Segara L. Jia N.L. Moore S.M. Henshall S.N. Birrell G.A. Coetzee R.L. Sutherland L.M. Butler W.D. Tilley 2009 Androgen receptor inhibits estrogen receptoralpha activity and is prognostic in breast cancer Cancer Res 69 6131 6140 10.1158/0008-5472.CAN-09-0452 19638585
43. V. Panet-Raymond B. Gottlieb L.K. Beitel L. Pinsky M.A. Trifiro 2000 Interactions between androgen and estrogen receptors and the effects on their transactivational properties Mol Cell Endocrinol 167 139 150 10.1016/S0303-7207(00)00279-3 11000528
44. M. Lanzino F. De Amicis M.J. McPhaul S. Marsico M.L. Panno S. Andò 2005 Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells J Biol Chem 280 20421 20430 10.1074/jbc.M413576200 15772083
45. A.G. Selim G. El-Ayat C.A. Wells 2002 Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors J Clin Pathol 55 14 16 11825917
46. T. Baqai S. Shousha 2003 Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast Histopathology (Oxf) 42 440 447 10.1046/j.1365-2559.2003.01612.x
47. P. Meijnen J.L. Peterse N. Antonini E.J. Rutgers M.J. van de Vijver 2008 Immunohistochemical categorisation of ductal carcinoma in situ of the breast Br J Cancer 98 137 142 10.1038/sj.bjc.6604112 18043578
48. A. Rody R. Diallo C. Poremba P. Wuelfing S. Kissler C. Solbach M. Kaufmann C. Jackisch 2005 Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor Appl Immunohistochem Mol Morphol 213 25 29
49. S.N. Agoff P.E. Swanson H. Linden S.E. Hawes T.J. Lawton 2003 Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations Am J Clin Pathol 120 725 731 10.1309/42F00D0DJD0J5EDT 14608899
50. E.A. Rakha M.E. El-Sayed A.R. Green A.H. Lee J.F. Robertson I.O. Ellis 2007 Prognostic markers in triple-negative breast cancer Cancer (Phila) 109 25 32 10.1002/cncr.22381
51. S.D. Conzen 2008 Minireview: nuclear receptors and breast cancer Mol Endocrinol 22 2215 2228 10.1210/me.2007-0421 18417735
52. C.M. Perou T. Sørlie M.B. Eisen M. van de Rijn S.S. Jeffrey C.A. Rees J.R. Pollack D.T. Ross H. Johnsen L.A. Akslen O. Fluge A. Pergamenschikov C. Williams S.X. Zhu P.E. Lønning A.L. Børresen-Dale P.O. Brown D. Botstein 2000 Molecular portraits of human breast tumours Nature (Lond) 406 747 752 10.1038/35021093
53. T. Sørlie C.M. Perou R. Tibshirani T. Aas S. Geisler H. Johnsen T. Hastie M.B. Eisen M. van de Rijn S.S. Jeffrey T. Thorsen H. Quist J.C. Matese P.O. Brown D. Botstein P. Eystein Lønning A.L. Børresen-Dale 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 10.1073/pnas. 191367098 11553815
54. T. Sørlie R. Tibshirani J. Parker T. Hastie J.S. Marron A. Nobel S. Deng H. Johnsen R. Pesich S. Geisler J. Demeter C.M. Perou P.E. Lønning P.O. Brown A.L. Børresen-Dale D. Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 10.1073/pnas.0932692100 12829800
55. T. Moriya A. Kasajima K. Ishida Y. Kariya J. Akahira M. Endoh M. Watanabe H. Sasano 2006 New trends of immunohistochemistry for making differential diagnosis of breast lesions Med Mol Morphol 39 8 13 10.1007/s00795-006-0309-8 16575508
56. S.J. Dawson E. Provenzano C. Caldas 2009 Triple negative breast cancers: clinical and prognostic implications Eur J Cancer 45 suppl1 27 40 10.1016/S0959-8049(09)70013-9 19775602
57. S.C. Linn L.J. Van't Veer 2009 Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept Eur J Cancer 45 suppl1 11 26 10.1016/S0959-8049(09)70012-7 19775601
58. P. Farmer H. Bonnefoi V. Becette M. Tubiana-Hulin P. Fumoleau D. Larsimont G. Macgrogan J. Bergh D. Cameron D. Goldstein S. Duss A.L. Nicoulaz C. Brisken M. Fiche M. Delorenzi R. Iggo 2005 Identification of molecular apocrine breast tumours by microarray analysis Oncogene 24 4660 4671 10.1038/sj.onc.1208561 15897907
59. C.A. Wells G.A. El-Ayat 2007 Non-operative breast pathology: apocrine lesions J Clin Pathol 60 1313 1320 10.1136/jcp.2006.040626 18042688
60. W.R. Miller J. Telford J.M. Dixon A.A. Shivas 1985 Androgen metabolism and apocrine differentiation in human breast cancer Breast Cancer Res Treat 5 67 73 10.1007/BF01807652 3978248
61. J.E. Celis T. Cabezón J.M. Moreira P. Gromov I. Gromova V. Timmermans-Wielenga T. Iwase F. Akiyama N. Honma F. Rank 2009 Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort Mol Oncol 3 220 237 10.1016/j.molonc.2009.01.005
62. H. Japaze J. Emina C. Diaz R.J. Schwam N. Gercovich G. Demonty E. Morgenfeld E. Rivarola E. Gil Deza F.G. Gercovich 2005 "Pure" invasive apocrine carcinoma of the breast: a new clinicopathological entity? Breast 14 3 10 10.1016/j.breast.2004.06.003 15695074
63. J.E. Celis P. Gromov T. Cabezón J.M. Moreira E. Friis K. Jirström A. Llombart-Bosch V. Timmermans-Wielenga F. Rank I. Gromova 2008 15-Prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma Mol Cell Proteomics 7 1795 1809 10.1074/mcp.R800011-MCP200 18632593